SAN FRANCISCO--(BUSINESS WIRE)--Aug. 9, 2006--Titan Pharmaceuticals, Inc. (AMEX: TTP - News) today announced financial results for the second quarter ended June 30, 2006. Net loss for the second quarter of 2006 was approximately $3.4 million, or $0.09 per share, compared to a net loss of approximately $5.7 million, or $0.18 per share, for the same period last year. The lower net loss in the second quarter of 2006 was the result of expense reduction strategies that the Company implemented last year, and reduced research and development expenses.
